Novel therapeutic targets in esophageal cancer: impact of chemokine receptor CXCR4

Future Oncol. 2007 Apr;3(2):119-22. doi: 10.2217/14796694.3.2.119.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Chemokine CXCL12
  • Chemokines, CXC / metabolism
  • Cyclin-Dependent Kinases / antagonists & inhibitors
  • Drug Delivery Systems / trends
  • Esophageal Neoplasms / drug therapy*
  • Esophageal Neoplasms / metabolism
  • Humans
  • Neoadjuvant Therapy
  • Receptors, CXCR4 / antagonists & inhibitors*
  • Receptors, CXCR4 / drug effects
  • Receptors, CXCR4 / metabolism

Substances

  • Antineoplastic Agents
  • CXCL12 protein, human
  • Chemokine CXCL12
  • Chemokines, CXC
  • Receptors, CXCR4
  • Cyclin-Dependent Kinases